Quality and sourcing concerns
DPP-4 inhibitors can be used as monotherapy when metformin is contraindicated or not tolerated
Common adverse effects of GLP-1 receptor agonists include: Gastrointestinal symptoms (nausea, vomiting, diarrhoea, constipation) Injection site reactions Headache Fatigue Dizziness Important safety considerations include: Risk of hypoglycaemia when used with insulin or sulfonylureas (dose reduction of these agents may be needed) Potential worsening of diabetic retinopathy with semaglutide in patients with pre-existing retinopathy [18] Risk of dehydration and acute kidney injury from persistent vomiting or diarrhoea Pancreatitis, gallbladder disease, and potential thyroid C-cell tumours (observed in rodent studies, though human relevance remains uncertain) [19] [20] Patients should be counselled about persistent severe abdominal pain as a potential warning sign of pancreatitis requiring immediate medical attention

The best fiber supplements for GLP-1 users, ranked After reviewing the clinical evidence, analyzing community experiences, and examining how each fiber type interacts with GLP-1 pharmacology, here are the top fiber supplements ranked by their overall suitability for people on these medications
Depth and frequency vary by goal, and are commonly summarized as follows: Regarding GHK-Cu timing , the enhanced-absorption logic favors application into the fresh channels